Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trialFriedrich Koehler, Karl Stangl, Kerstin Koehler et al.|The Lancet|2018Cited by 734
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Harmony R. Reynolds, Alexis F. Turgeon et al.|Bristol Research (University of Bristol)|2021Cited by 589
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L. Houston, Ryan Zarychanski, Patrick R. Lawler et al.|Clinical Trials|2020Cited by 68
Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trialFriedrich Koehler, Stefan D. Anker, Kerstin Koehler et al.|The Lancet Digital Health|2019Cited by 61
Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19Ryan Zarychanski, Patrick R. Lawler, Ewan C. Goligher et al.|medRxiv|2021Cited by 19